Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Direktor, Zentrum für Kinder- und Jugendmedizin
Aktuelle Veranstaltungen
-
WiSe 2025
- Anleitung zu wiss. Arbeiten für Mediziner und Naturwissenschaftler
- Ausbildung Kinderklinik für den 3. klin. Studienabschnitt (WP)
- Kinderheilkunde Blockpraktikum (PV)
- Wahlfach: Spezielle Pädiatrie (PV)
- Kursus der allgemeinen pädiatrisch-klinischen Untersuchungen
- Additive Fertigungsverfahren 2 – Kunststoffverarbeitung - IW PC
- Kinderheilkunde Vorlesung Teil I (WA)
Vergangene Veranstaltungen (max. 10)
-
SoSe 2025
-
WiSe 2024
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Effects of a Low Versus Moderate–High Intense Exercise Program on Innate Immune Recovery, Fitness, and Quality of Life During Pediatric Allo‐HSCT : The ANIMAL Exploratory Randomized Controlled TrialIn: Pediatric Blood and Cancer, Jg. 72, 2025, Nr. 8, e31826DOI (Open Access)
-
Impact of treosulfan exposure on clinical outcome after allogeneic stem cell transplantation in children : A substudy of 2 phase 2 trialsIn: British Journal of Clinical Pharmacology (BJCP), Jg. 91, 2025, Nr. 3, S. 882 – 893
-
Improved outcomes and treatment guidance in pediatric therapy-related AML : AML-BFM study group recommendationsIn: Blood Advances, Jg. 9, 2025, Nr. 11, S. 2831 – 2841DOI (Open Access)
-
Influence of Nucleophosmin (NPM1) Genotypes on Outcome of Patients With AML : An AIEOP-BFM and COG-SWOG Intergroup CollaborationIn: Journal of Clinical Oncology (JCO), Jg. 43, 2025, Nr. 8, S. 972 – 984
-
No evidence of leukaemia (NEL) as a response criteria in paediatric AML : A multicentre analysisIn: eClinicalMedicine, Jg. 84, 2025, 103272DOI (Open Access)
-
Outcomes with intensive treatment for acute myeloid leukemia : an analysis of two decades of data from the HARMONY AllianceIn: Haematologica / The Hematology Journal, Jg. 110, 2025, Nr. 5, S. 1126 – 1140DOI (Open Access)
-
Perspektiven von Familien mit (schwer-)kranken Kindern und Jugendlichen in Niedersachsen : Versorgung und Unterstützung im Fokus-Analyse der aktuellen Situation und möglicher UnterstützungsangeboteIn: Das Gesundheitswesen, Jg. 87, 2025, Nr. 11, S. 671 – 677
-
Pflegerische und ärztlich delegierbare Maßnahmen bei päd.-onkologischen Patienten als ambulant aufsuchende Versorgung : Das Projekt KIKHomeCareIn: Klinische Pädiatrie, Jg. 237, 2025, Nr. 03, S. 153 – 160
-
Predisposition Footprints in the Somatic Genome of Wilms TumorsIn: Cancer Discovery, Jg. 15, 2025, Nr. 2, S. 286 – 298DOI, Online Volltext (Open Access)
-
Prognostic Value of Molecular Genetic Measurable Residual Disease (MRD) Monitoring in Pediatric Acute Myeloid Leukemia Expressing KMT2A::MLLT10In: European Journal of Haematology, Jg. 115, 2025, Nr. 5, S. 493 – 504DOI (Open Access)
-
The impact of a single HIIT intervention on the mobilization of NK cells and ILCs in adolescents and young adults (AYA) undergoing cancer treatment : An interventional controlled trialIn: BMC Cancer, Jg. 25, 2025, Nr. 1, 689DOI (Open Access)
-
Unravelling the Significance of Extracellular Vesicle-Associated DNA in Cancer Biology and Its Potential Clinical ApplicationsIn: Journal of Extracellular Vesicles (JEV), Jg. 14, 2025, Nr. 3, e70047DOI (Open Access)
-
Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid LeukaemiaIn: Pediatric Blood and Cancer, Jg. 72, 2025, Nr. 7, e31714DOI (Open Access)
-
Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic LeukemiaIn: Pediatric Blood and Cancer, Jg. 72, 2025, Nr. 6, e31630DOI (Open Access)
-
Altered enhancer-promoter interaction leads to MNX1 expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13)In: Blood Advances, Jg. 8, 2024, Nr. 19, S. 5100 – 5111DOI (Open Access)
-
Die ambulant-aufsuchende Versorgung von an Krebs erkrankten Kindern aus Sicht der Erziehungsberechtigten : Eine qualitative EvaluationsstudieIn: Klinische Pädiatrie, Jg. 236, 2024, Nr. 3, S. 165 – 172
-
Feasibility, efficacy, and safety of animal-assisted activities with visiting dogs in inpatient pediatric oncologyIn: World Journal of Pediatrics (WJP), Jg. 20, 2024, Nr. 9, S. 915 – 924DOI (Open Access)
-
Guideline for treating relapsed or refractory myeloid leukemia in children with Down syndromeIn: Pediatric Blood and Cancer, Jg. 71, 2024, Nr. 9, e31141DOI (Open Access)
-
High Parathyroid Hormone Rather than Low Vitamin D Is Associated with Reduced Event-Free Survival in Childhood CancerIn: Cancer Epidemiology, Biomarkers & Prevention, Jg. 33, 2024, Nr. 11, S. 1414 – 1422DOI (Open Access)
-
Kardiovaskuläre Toxizität der Therapie onkologischer Erkrankungen bei Kindern und Jugendlichen : Positionspapier zu Aspekten der kardiologischen Betreuung und NachsorgeIn: Monatsschrift Kinderheilkunde, Jg. 172, 2024, Nr. Suppl. 1, S. 14 – 42DOI (Open Access)
-
Netzwerk ActiveOncoKids : Zentralisierte Sportberatung im deutschsprachigen Raum für Kinder, Jugendliche und junge Erwachsene in allen onkologischen BehandlungsphasenIn: Klinische Pädiatrie, Jg. 236, 2024, Nr. 6, S. 321 – 330DOI (Open Access)
-
Osteosarcomas in retinoblastoma-survivors : A report of 28 affected patients from the Cooperative Osteosarcoma Study Group (COSS)In: EJC Paediatric Oncology, Jg. 3, 2024, 100158DOI (Open Access)
-
Panel-based RNA fusion sequencing improves diagnostics of pediatric acute myeloid leukemiaIn: Leukemia, Jg. 38, 2024, Nr. 3, S. 538 – 544DOI (Open Access)
-
Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications : A HARMONY studyIn: Leukemia, Jg. 38, 2024, Nr. 9, S. 1929 – 1937DOI (Open Access)
-
Selective pressures of platinum compounds shape the evolution of therapy-related myeloid neoplasmsIn: Nature Communications, Jg. 15, 2024, Nr. 1, 6025DOI (Open Access)
-
Severely reduced physical performance is already present at the time of admission for stem cell transplantationIn: BMJ Open Sport & Exercise Medicine, Jg. 10, 2024, Nr. 2, e001907DOI, Online Volltext (Open Access)
-
The PedAL/EuPAL Project : A Global Initiative to Address the Unmet Medical Needs of Pediatric Patients with Relapsed or Refractory Acute Myeloid LeukemiaIn: Cancers, Jg. 16, 2024, Nr. 1, 78DOI (Open Access)
-
Treosulfan vs busulfan conditioning for allogeneic bmt in children with nonmalignant disease : A randomized phase 2 trialIn: Bone Marrow Transplantation, Jg. 59, 2024, Nr. 1, S. 107 – 116DOI (Open Access)
-
Y-box binding protein 1 in small extracellular vesicles reduces mesenchymal stem cell differentiation to osteoblasts : implications for acute myeloid leukaemiaIn: Journal of Extracellular Vesicles (JEV), Jg. 13, 2024, Nr. 3, e12417DOI, Online Volltext (Open Access)
-
A novel cancer risk prediction score for the natural course of FA patients with biallelic BRCA2/FANCD1 mutationsIn: Human Molecular Genetics, Jg. 32, 2023, Nr. 11, S. 1836 – 1849
-
Comprehensive single-cell genome analysis at nucleotide resolution using the PTA Analysis ToolboxIn: Cell Genomics, Jg. 3, 2023, Nr. 9, 100389DOI (Open Access)
-
Extracellular vesicles transfer chromatin-like structures that induce non-mutational dysfunction of p53 in bone marrow stem cellsIn: Cell Discovery, Jg. 9, 2023, Nr. 1, 12DOI (Open Access)
-
Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia : An I-BFM Study Group collaborationIn: Blood Advances, Jg. 7, 2023, Nr. 6, S. 1045 – 1055DOI (Open Access)
-
Is an Exercise Program for Pediatric Cancer Patients in Palliative Care Feasible and Supportive? : A Case SeriesIn: Children, Jg. 10, 2023, Nr. 2, 318DOI, Online Volltext (Open Access)
-
Kardiologische Betreuung und Nachsorge bei Kindern und Jugendlichen nach onkologischer Therapie : Kurzfassung des Positionspapiers zur kardiovaskulären Toxizität der Therapie onkologischer Erkrankungen des Kindes- und JugendaltersIn: Monatsschrift Kinderheilkunde, Jg. 171, 2023, Nr. 10, S. 926 – 928
-
Myeloid leukemia vulnerabilities embedded in long noncoding RNA locus MYNRL15In: iScience, Jg. 26, 2023, Nr. 10, 107844DOI (Open Access)
-
Physical activity in 9–15 year-old pediatric cancer survivors compared to a nationwide sampleIn: Journal of Cancer Research and Clinical Oncology, Jg. 149, 2023, Nr. 8, S. 4719 – 4729DOI (Open Access)
-
RUNX1 isoform disequilibrium promotes the development of trisomy 21–associated myeloid leukemiaIn: Blood, Jg. 141, 2023, Nr. 10, S. 1105 – 1118DOI (Open Access)
-
RUNX1 mutation has no prognostic significance in paediatric AML : A retrospective study of the AML-BFM study groupIn: Leukemia, Jg. 37, 2023, Nr. 7, S. 1435 – 1443DOI (Open Access)
-
Single Molecule Localization Microscopy for Studying Small Extracellular VesiclesIn: Small, Jg. 19, 2023, Nr. 12, 2205030DOI (Open Access)
-
Understanding WT1 Alterations and Expression Profiles in Hematological MalignanciesIn: Cancers, Jg. 15, 2023, Nr. 13, 3491DOI, Online Volltext (Open Access)
-
DNA in extracellular vesicles : From evolution to its current application in health and diseaseIn: Cell and Bioscience, Jg. 12, 2022, Nr. 1, 37DOI, Online Volltext (Open Access)
-
Design and Evaluation of an Outdoor Exercise Program for Pediatric Cancer SurvivorsIn: Children, Jg. 9, 2022, Nr. 8, 1117DOI, Online Volltext (Open Access)
-
Effects of an Exercise Intervention on Gait Function in Young Survivors of Osteosarcoma with Megaendoprosthesis of the Lower Extremity : Results from the Pilot Randomized Controlled Trial proGAITIn: Current Oncology, Jg. 29, 2022, Nr. 10, S. 7754 – 7767DOI, Online Volltext (Open Access)
-
Efficient Small Extracellular Vesicles (EV) Isolation Method and Evaluation of EV-Associated DNA Role in Cell–Cell Communication in CancerIn: Cancers, Jg. 14, 2022, Nr. 9, 2068DOI (Open Access)
-
Ein individualisiertes Bewegungsprogramm für kinderonkologische Patienten in palliativen Situationen mithilfe von HausbesuchenIn: Bewegungstherapie und Gesundheitssport B&G, Jg. 38, 2022, Nr. 05, S. 235 – 240
-
Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological MalignanciesIn: Frontiers in Immunology, Jg. 13, 2022, 847008DOI, Online Volltext (Open Access)
-
Global effort to evacuate Ukrainian children with cancer and blood disorders who have been affected by warIn: The Lancet Haematology, Jg. 9, 2022, Nr. 9, S. e645 – e647DOI (Open Access)
-
Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDSIn: Haematologica / The Hematology Journal, Jg. 107, 2022, Nr. 3, S. 759 – 4764DOI (Open Access)
-
Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia : Results from a phase II trialIn: Leukemia, Jg. 36, 2022, Nr. 6, S. 1516 – 1524DOI (Open Access)
-
Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AMLIn: Frontiers in Pediatrics, Jg. 10, 2022, 1046586DOI (Open Access)
-
Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients : A Retrospective Study by the I-BFM Study GroupIn: Biomedicines, Jg. 10, 2022, Nr. 7, 1530DOI (Open Access)
-
Network Oncolgy Specialist Advisory Service : A Survey of the Psychosocial Situation of Long Term Cancer Survivors During Childhood or Adolescents
34. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung, 1-4. Juni 2022, Wilsede,In: Klinische Pädiatrie, Jg. 234, 2022, Nr. 3, 34. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung, S. 138 – 145 -
Optical Genome Mapping as a Diagnostic Tool in Pediatric Acute Myeloid LeukemiaIn: Cancers, Jg. 14, 2022, Nr. 9, 2058DOI, Online Volltext (Open Access)
-
Pediatric Acute Myeloid Leukemia : Past, Present, and FutureIn: Journal of Clinical Medicine (JCM), Jg. 11, 2022, Nr. 3, 504DOI, Online Volltext (Open Access)
-
Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia : A retrospective cohort study of the Relapsed AML 2001/01 StudyIn: Pediatric Blood and Cancer, Jg. 69, 2022, Nr. 1, e29341
-
Screening and diagnosis of hemoglobinopathies in Germany: Current state and future perspectivesIn: Scientific Reports, Jg. 12, 2022, Nr. 1, 9762DOI, Online Volltext (Open Access)
-
The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesisIn: Blood, Jg. 139, 2022, Nr. 5, S. 651 – 665DOI (Open Access)
-
A Study of Regulatory Challenges of Pediatric Oncology Phase I/II Trial Submissions and Guidance on Protocol DevelopmentIn: Clinical Pharmacology & Therapeutics, Jg. 110, 2021, Nr. 4, S. 1025 – 1037DOI (Open Access)
-
A homozygous nonsense mutation early in exon 5 of BRCA2 is associated with very severe Fanconi anemiaIn: European Journal of Medical Genetics (EJMG), Jg. 64, 2021, Nr. 8, 104260
-
BCR-ABL1 positive AML or CML in blast crisis? A pediatric case report with inv(3) and t(9;22) in the initial cloneIn: Cancer Genetics, Jg. 254-255, 2021, S. 70 – 74DOI (Open Access)
-
Eye tumors in childhood as first sign of tumor predisposition syndromes : Insights from an observational study conducted in Germany and AustriaIn: Cancers, Jg. 13, 2021, Nr. 8, S. 1876DOI, Online Volltext (Open Access)
-
Far from Health : The Bone Marrow Microenvironment in AML, A Leukemia Supportive ShelterIn: Children, Jg. 8, 2021, Nr. 5, 371DOI, Online Volltext (Open Access)
-
Impact of kmt2a rearrangement and cspg4 expression in pediatric acute myeloid leukemiaIn: Cancers, Jg. 13, 2021, Nr. 19, 4817DOI, Online Volltext (Open Access)
-
Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic IndicatorsIn: Blood Cancer Discovery, Jg. 2, 2021, Nr. 6, S. 586 – 599DOI (Open Access)
-
Managing Adverse Events Associated with Dinutuximab Beta Treatment in Patients with High-Risk Neuroblastoma : Practical GuidanceIn: Pediatric Drugs, Jg. 23, 2021, Nr. 6, S. 537 – 548DOI (Open Access)
-
Molekulare Tumortherapie : Phase-I/II-Netzwerkstruktur der Gesellschaft für Pädiatrische Onkologie und HämatologieIn: Der Onkologe, Jg. 27, 2021, Nr. 5, S. 447 – 457
-
Pediatric Cancer Data Commons : Federating and Democratizing Data for Childhood Cancer ResearchIn: JCO Clinical Cancer Informatics (JCO CCI), Jg. 5, 2021, S. 1034 – 1043DOI (Open Access)
-
Recommendations for Diagnosis and Treatment of Children with Transient Abnormal Myelopoiesis (TAM) and Myeloid Leukemia in Down Syndrome (ML-DS)In: Klinische Pädiatrie, Jg. 233, 2021, Nr. 06, S. 267 – 277
-
Redirecting the immune microenvironment in acute myeloid leukemiaIn: Cancers, Jg. 13, 2021, Nr. 6, S. 1423DOI, Online Volltext (Open Access)
-
Second relapse of pediatric patients with acute myeloid leukemia : A report on current treatment strategies and outcome of the AML-BFM study groupIn: Cancers, Jg. 13, 2021, Nr. 4, S. 789DOI, Online Volltext (Open Access)
-
Survival following relapse in children with acute myeloid leukemia : A report from aml-bfm and cogIn: Cancers, Jg. 13, 2021, Nr. 10, S. 2336DOI, Online Volltext (Open Access)
-
The Pediatric Precision Oncology INFORM Registry : Clinical Outcome and Benefit for Patients with Very High-Evidence TargetsIn: Cancer Discovery, Jg. 11, 2021, Nr. 11, S. 2764 – 2779DOI (Open Access)
-
Comprehensive assessments and related interventions to enhance the long-term outcomes of child, adolescent and young adult cancer survivors - Presentation of the CARE for CAYA-Program study protocol and associated literature reviewIn: BMC Cancer, Jg. 20, 2020, Nr. 1, 16DOI (Open Access)
-
Correction: Hematopoietic stem cell transplantation for children with acute myeloid leukemia—results of the AML SCT-BFM 2007 trialIn: Leukemia, Jg. 34, 2020, S. 1486DOI (Open Access)
-
Early deaths from childhood cancer in Germany 1980-2016In: Cancer Epidemiology, Jg. 65, 2020, 101669
-
Evaluation of dsDNA from extracellular vesicles (EVs) in pediatric AML diagnosticsIn: Annals of Hematology, Jg. 99, 2020, Nr. 3, S. 459 – 475
-
Exposure of Patient-Derived Mesenchymal Stromal Cells to TGFB1 Supports Fibrosis Induction in a Pediatric Acute Megakaryoblastic Leukemia ModelIn: Molecular Cancer Research, Jg. 18, 2020, Nr. 10, S. 1603 – 1612
-
Genotyping circulating tumor DNA of pediatric Hodgkin lymphomaIn: Leukemia, Jg. 34, 2020, Nr. 1, S. 151 – 166
-
Hematopoietic stem cell transplantation for children with acute myeloid leukemia—results of the AML SCT-BFM 2007 trialIn: Leukemia, Jg. 34, 2020, Nr. 2, S. 613 – 624
-
Insights into the limitations of transient expression systems for the functional study of p53 acetylation site and oncogenic mutantsIn: Biochemical and Biophysical Research Communications (BBRC), Jg. 524, 2020, Nr. 4, S. 990 – 995
-
Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemiaIn: British Journal of Haematology, Jg. 190, 2020, Nr. 2, S. 198 – 208DOI, Online Volltext (Open Access)
-
Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia : a retrospective I-BFM analysis of 333 childrenIn: British Journal of Haematology, Jg. 189, 2020, Nr. 4, S. 745 – 750DOI (Open Access)
-
Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents : ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationIn: European Journal of Cancer (EJC), Jg. 136, 2020, S. 116 – 129DOI (Open Access)
-
Phospho-Profiling Linking Biology and Clinics in Pediatric Acute Myeloid LeukemiaIn: HemaSphere: Open Access Journal of the European Hematology Association, Jg. 4, 2020, Nr. 1, S. e312DOI (Open Access)
-
Social inequalities in the participation and activity of children and adolescents with leukemia, brain tumors, and sarcomas (SUPATEEN) : a protocol for a multicenter longitudinal prospective observational studyIn: BMC Pediatrics, Jg. 20, 2020, Nr. 1, S. 48DOI (Open Access)
-
Veno-Venous Extracorporeal Membrane Oxygenation in Adult Patients with Sickle Cell Disease and Acute Chest Syndrome : a Single-Center ExperienceIn: Hemoglobin, Jg. 44, 2020, Nr. 2, S. 71 – 77
-
Detection of AML-specific mutations in pediatric patient plasma using extracellular vesicle–derived RNAIn: Annals of Hematology, Jg. 98, 2019, Nr. 3, S. 595 – 603
-
Gemtuzumab ozogamicin in children with relapsed or refractory acute myeloid leukemia : a report by Berlin-Frankfurt-Münster study groupIn: Haematologica / The Hematology Journal, Jg. 104, 2019, Nr. 1, S. 120 – 127DOI, Online Volltext (Open Access)
-
Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down SyndromeIn: Cancer Cell, Jg. 36, 2019, Nr. 2, S. 123 – 138.e10DOI (Open Access)
-
Mutated WT1, FLT3-ITD, and NUP98-NSD1 Fusion in Various Combinations Define a Poor Prognostic Group in Pediatric Acute Myeloid LeukemiaIn: Journal of Oncology, 2019, 1609128DOI (Open Access)
-
Phase 1–2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemiaIn: British Journal of Haematology, Jg. 186, 2019, Nr. 3, S. e7 – e11DOI (Open Access)
-
Phase I dose-escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumorsIn: Pediatric Blood and Cancer, Jg. 66, 2019, Nr. 10, e27900DOI, Online Volltext (Open Access)
-
Akute Promyelozyten-Leukämie : Neue Behandlungsstrategien mit ATRA und ATO – AML-BFM-EmpfehlungenIn: Klinische Pädiatrie, Jg. 230, 2018, Nr. 6, S. 299 – 304
-
An effective modestly intensive re-induction regimen with bortezomib in relapsed or refractory paediatric acute lymphoblastic leukaemiaIn: British Journal of Haematology, Jg. 181, 2018, Nr. 4, S. 523 – 527
-
Cardio-toxicity in childhood cancer survivors “Cure is not enough”In: Journal of Thoracic Disease, Jg. 10, 2018, S. S4344 – S4350DOI (Open Access)
-
Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia : A phase IB studyIn: Haematologica / The Hematology Journal, Jg. 103, 2018, Nr. 9, S. 1484 – 1492DOI (Open Access)
-
Endogenous tumor suppressor microRNA-193b : Therapeutic and prognostic value in acute myeloid leukemiaIn: Journal of Clinical Oncology (JCO), Jg. 36, 2018, Nr. 10, S. 1007 – 1016DOI (Open Access)
-
International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemiaIn: Blood, Jg. 132, 2018, Nr. 3, S. 264 – 276DOI (Open Access)
-
Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome : TMD Prevention 2007 studyIn: Blood Advances, Jg. 2, 2018, Nr. 13, S. 1532 – 1540DOI (Open Access)
-
Panton-Valentine Leukocidin associated with S. aureus osteomyelitis activates platelets via neutrophil secretion productsIn: Scientific Reports, Jg. 8, 2018, Nr. 1, S. 2185DOI (Open Access)
-
Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML : a retrospective study by the I-BFM Study GroupIn: Blood, Jg. 132, 2018, Nr. 15, S. 1584 – 1592DOI (Open Access)
-
Single-cell whole exome and targeted sequencing in NPM1/FLT3 positive pediatric acute myeloid leukemiaIn: Pediatric Blood and Cancer, Jg. 65, 2018, Nr. 2, S. e26848
-
Spontaneous reversion of a lineage switch following an initial blinatumomab-induced ALL-to-AML switch in MLL-rearranged infant ALLIn: Blood Advances, Jg. 2, 2018, Nr. 12, S. 1382 – 1385DOI (Open Access)
-
Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012In: Leukemia, Jg. 32, 2018, S. 2167 – 2177DOI (Open Access)
-
The genetic basis and cell of origin of mixed phenotype acute leukaemiaIn: Nature, Jg. 562, 2018, Nr. 7727, S. 373 – 379DOI, Online Volltext (Open Access)
-
Two cancer-predisposing variants in one family : Incidental finding of a fumarate hydrogenase (FH) germline variant in a family with Li–Fraumeni syndromeIn: Pediatric Blood and Cancer, Jg. 65, 2018, Nr. 10, e27254
-
A common ancestral DNMT3A-mutated preleukemic clone giving rise to AML and MDS in an adolescent girlIn: Leukemia and Lymphoma, Jg. 58, 2017, Nr. 3, S. 718 – 721
-
A specific dietary intervention to restore brain structure and function after ischemic strokeIn: Theranostics, Jg. 7, 2017, Nr. 2, S. 493 – 512DOI (Open Access)
-
Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groupsIn: Pediatric Blood and Cancer, Jg. 64, 2017, Nr. 12, S. e26664DOI (Open Access)
-
Childhood cancer predisposition syndromes : A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and HematologyIn: American Journal of Medical Genetics, Part A, Jg. 173, 2017, Nr. 4, S. 1017 – 1037
-
Feasibility and Toxicity of Simultaneously Administrated Chemotherapy and Proton Therapy in Children and Adolescents
49th Congress of the International Society of Paediatric Oncology (SIOP), October 12–15, 2017, Washington, DC, USA,In: Pediatric Blood and Cancer, Jg. 64, 2017, Nr. Suppl. 3, S. S339 -
First experience of the AML-Berlin-Frankfurt-Münster group in pediatric patients with standard-risk acute promyelocytic leukemia treated with arsenic trioxide and all-trans retinoid acidIn: Pediatric Blood and Cancer, Jg. 64, 2017, Nr. 8, e26461
-
Genotype-outcome correlations in pediatric AML : the impact of a monosomal karyotype in trial AML-BFM 2004In: Leukemia, Jg. 31, 2017, Nr. 12, S. 2807 – 2814DOI (Open Access)
-
Lowe-dose cytarabine treatment in children with down syndrome and transient Myeloproferative disorder to prevent ML-DS : AML-BFM TMD Prevention 2007 StudyIn: Haematologica / The Hematology Journal, Jg. 102, 2017, Nr. Suppl. 2, S. 322 – 322
-
Pediatric non–Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomesIn: Nature Genetics, Jg. 49, 2017, Nr. 3, S. 451 – 456DOI, Online Volltext (Open Access)
-
Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapyIn: Annals of Hematology, Jg. 96, 2017, Nr. 9, S. 1449 – 1456
-
The non-coding RNA landscape of human hematopoiesis and leukemiaIn: Nature Communications, Jg. 8, 2017, Nr. 1, S. 218DOI, Online Volltext (Open Access)
-
Therapy reduction in patients with Down syndrome and myeloid leukemia : the international ML-DS 2006 trialIn: Blood, Jg. 129, 2017, Nr. 25, S. 3314 – 3321DOI (Open Access)
-
Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groupsIn: Cancer, Jg. 122, 2016, Nr. 24, S. 3821 – 3830DOI (Open Access)
-
Coexpression of Multiple ABC-Transporters is Strongly Associated with Treatment Response in Childhood Acute Myeloid LeukemiaIn: Pediatric Blood and Cancer, Jg. 63, 2016, Nr. 2, S. 242 – 247
-
Dose-related efficacy and toxicity of gemtuzumab ozogamicin in pediatric acute myeloid leukemiaIn: Expert Review of Anticancer Therapy, Jg. 16, 2016, Nr. 2, S. 137 – 146DOI (Open Access)
-
Evaluation der spezialisierten ambulanten pädiatrischen Palliativversorgung in Niedersachsen – Eine qualitative Studie zur ElternsichtIn: Das Gesundheitswesen, Jg. 78, 2016, Nr. 5, S. 306 – 312
-
Exchange Transfusion and Leukapheresis in Pediatric Patients with AML With High Risk of Early Death by Bleeding and LeukostasisIn: Pediatric Blood and Cancer, Jg. 63, 2016, Nr. 4, S. 640 – 645
-
Hematologic Response to Vorinostat Treatment in Relapsed Myeloid Leukemia of Down SyndromeIn: Pediatric Blood and Cancer, Jg. 63, 2016, Nr. 9, S. 1677 – 1679
-
Identification of a Cryptic Insertion ins(11;X)(q23;q28q12) Resulting in a KMT2A-FLNA Fusion in a 13-Month-Old Child with Acute Myelomonocytic LeukemiaIn: Cytogenetics and Cell Genetics, Jg. 150, 2016, Nr. 3-4, S. 281 – 286
-
Infectious Complications in Children With Acute Myeloid Leukemia and Down Syndrome : Analysis of the Prospective Multicenter Trial AML-BFM 2004In: Pediatric Blood and Cancer, Jg. 63, 2016, Nr. 6, S. 1070 – 1074
-
Infectious complications in children with acute myeloid leukemia : decreased mortality in multicenter trial AML-BFM 2004In: Blood Cancer Journal, Jg. 6, 2016, S. e382DOI (Open Access)
-
Lack of Effectiveness of Neutropenic Diet and Social Restrictions as Anti-Infective Measures in Children With Acute Myeloid Leukemia : An Analysis of the AML-BFM 2004 TrialIn: Journal of Clinical Oncology (JCO), Jg. 34, 2016, Nr. 23, S. 2776 – 2783DOI, Online Volltext (Open Access)
-
MIR-139-5p controls translation in myeloid leukemia through EIF4G2In: Oncogene, Jg. 35, 2016, Nr. 14, S. 1822 – 1831
-
MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemiaIn: OncoTarget, Jg. 7, 2016, Nr. 30, S. 48412 – 48422DOI (Open Access)
-
Netzwerk für onkologische Fachberatung (NOF) – Modellprojekt für (Langzeit-) Nachsorge nach einer Krebserkrankung im Kindes- und JugendalterIn: Klinische Pädiatrie, Jg. 228, 2016, Nr. 06/07, S. 325 – 331
-
Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot studyIn: European Journal of Cancer (EJC), Jg. 65, 2016, S. 91 – 101
-
Optimized human CYP4B1 in combination with the alkylator prodrug 4-ipomeanol serves as a novel suicide gene system for adoptive T-cell therapiesIn: Gene Therapy, Jg. 23, 2016, Nr. 7, S. 615 – 626
-
PHF6 mutations in paediatric acute myeloid leukaemiaIn: British Journal of Haematology, Jg. 175, 2016, Nr. 5, S. 967 – 971
-
Pädiatrische Onkologie : Behandlungsstrukturen und aktuelle HerausforderungenIn: Der Onkologe, Jg. 22, 2016, Nr. 12, S. 904 – 907
-
Recurrent abnormalities can be used for risk group stratification in pediatric AMKL : a retrospective intergroup studyIn: Blood, Jg. 127, 2016, Nr. 26, S. 3424 – 3430DOI (Open Access)
-
Additional treatment with 2-Chloro-2-Deoxyadenosine during consolidation in children with high-risk acute myeloid leukemia does not improve survivalIn: Leukemia, Jg. 29, 2015, Nr. 11, S. 2260 – 2263
-
Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML : Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study GroupIn: Journal of Clinical Oncology (JCO), Jg. 33, 2015, Nr. 36, S. 4247 – 4258DOI, Online Volltext (Open Access)
-
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid LeukemiaIn: Journal of Clinical Oncology (JCO), Jg. 33, 2015, Nr. 27, S. 2949 – 2962DOI, Online Volltext (Open Access)
-
Family History and Relapse in Pediatric Acute Myeloid LeukemiaIn: Pediatric Blood and Cancer, Jg. 62, 2015, Nr. 12, S. 2235 – 2237
-
Gene Expression Profiles Associated with Pediatric Relapsed AMLIn: PLoS ONE, Jg. 10, 2015, Nr. 4, S. e0121730DOI (Open Access)
-
Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia : a retrospective international studyIn: Blood, Jg. 126, 2015, Nr. 13, S. 1575 – 1584DOI (Open Access)
-
Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trialIn: Annals of Hematology, Jg. 94, 2015, Nr. 8, S. 1327 – 1336DOI (Open Access)
-
Patients' Adherence in the Maintenance Therapy of Children and Adolescents with Acute Lymphoblastic LeukemiaIn: Klinische Pädiatrie, Jg. 227, 2015, Nr. 6 / 7, S. 329 – 334
-
Prospective Validation of a New Method of Monitoring Minimal Residual Disease in Childhood Acute Myelogenous LeukemiaIn: Clinical Cancer Research, Jg. 21, 2015, Nr. 6, S. 1353 – 1359
-
Randomised Introduction of 2-CDA as Intensification during Consolidation for Children with High-risk AML – Results from Study AML-BFM 2004In: Klinische Pädiatrie, Jg. 227, 2015, Nr. 3, S. 116 – 122
-
Recurrent deletions of IKZF1 in pediatric acute myeloid leukemiaIn: Haematologica / The Hematology Journal, Jg. 100, 2015, Nr. 9, S. 1151 – 1159DOI (Open Access)
-
Response monitoring of infant acute myeloid leukemia treatment by quantification of the tumor specific MLL-FNBP1 fusion geneIn: Leukemia and Lymphoma, Jg. 56, 2015, Nr. 3, S. 793 – 796
-
Somatic thrombopoietin (THPO) gene mutations in childhood myeloid leukemiasIn: International Journal of Hematology, Jg. 102, 2015, Nr. 1, S. 140 – 143
-
Subtype prediction in pediatric acute myeloid leukemia : classification using differential network rank conservation revisitedIn: BMC Bioinformatics, Jg. 16, 2015, S. 305DOI (Open Access)
-
Clinical relevance of molecular aberrations in paediatric acute myeloid leukaemia at first relapseIn: British Journal of Haematology, Jg. 166, 2014, Nr. 6, S. 902 – 910
-
Re-induction with L-DNR/FLAG improves response after AML relapse, but not long-term survivalIn: Klinische Pädiatrie, Jg. 226, 2014, Nr. 6-7, S. 323 – 331
-
The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia : results of the international study Relapsed AML 2001/01In: Haematologica / The Hematology Journal, Jg. 99, 2014, Nr. 9, S. 1472 – 1478DOI (Open Access)
-
Allo-SCT using BU, CY and melphalan for children with AML in second CRIn: Bone Marrow Transplantation, Jg. 48, 2013, Nr. 5, S. 651 – 656
-
Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: Results from study AML-BFM 2004In: Blood, Jg. 122, 2013, Nr. 1, S. 37 – 43
-
Favorable outcome in infants with AML after intensive first- and second-line treatment: An AML-BFM study group reportIn: Leukemia, Jg. 26, 2012, Nr. 4, S. 654 – 661DOI (Open Access)
-
The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: Results from the AML-BFM 98 studyIn: Haematologica, the hematology journal, Jg. 97, 2012, Nr. 1, S. 21 – 29DOI (Open Access)
-
CNS irradiation in pediatric acute myleoid leukemia : equal results by 12 or 18 Gy in studies AML-BFM98 and 2004In: Pediatric Blood and Cancer, Jg. 57, 2011, Nr. 6, S. 986 – 992
-
Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline dosesIn: British Journal of Haematology, Jg. 149, 2010, Nr. 3, S. 399 – 409
-
Real-time PCR-based post-transplant monitoring of haematopoietic chimerism : an option for earlier detection of impending relapse in paediatric AMLIn: Bone Marrow Transplantation, Jg. 45, 2010, Nr. Suppl. 2, S. S263
-
Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effectiveIn: Bone Marrow Transplantation, Jg. 33, 2004, Nr. 8, S. 815 – 821
-
Addition of Anti-T-Lymphocyte-Globuline As Graft Versus Host Disease Prophylaxis for Matched Unrelated Donors Equalizes Outcomes with Matched Sibling Donors : Results from the AML SCT-BFM 2007 Trial
The 66th ASH Annual Meeting, December 7-10, 2024, San Diego, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 144, 2024, Nr. Suppl. 1, S. 3563DOI (Open Access) -
Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia : Results of the AML BFM Study Group
The 66th ASH Annual Meeting, December 7-10, 2024, San Diego, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 144, 2024, Nr. Supplement 1, S. 3548DOI (Open Access) -
Collaborative data sharing : The International Acute Myeloid Leukemia Consortium (INTERACT)
ASCO Breakthrough: A Global Summit for Oncology Innovators; AUG 08-10, 2024; Yokohama, Japan,In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. Suppl. 23, S. 169 – 169 -
Independent, International Validation and Refinement of a Machine Learning Algorithm to Classify Acute Leukemia Using Routine Laboratory FeaturesIn: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 144, 2024, Nr. Suppl. 1, S. 790 – 791DOI (Open Access)
-
Inhibition of small EVs secretion and its implication on cytoplasmic DNA sensing and cancer immunogenicity in AML
35. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung, 05.–08.06.2024, Wilsede, Germany,In: Klinische Pädiatrie. Stuttgart: Thieme, Jg. 236, 2024, Nr. 3, S. 205 – 206 -
Significance of RT-qPCR-Based Measurable Residual Disease for Optimizing the Treatment of Pediatric Acute Myeloid Leukemia
66th ASH Annual Meeting, December 7-10, 2024, San Diego, CA, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 144, 2024, Nr. Supplement 1, S. 228 – 229DOI (Open Access) -
AML-derived small EVs containing YBX1 influences mesenchymal stromal cells differentiation in the bone marrow niche
34. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung ; 31.05 – 03.06.2023, Wilsede, Germany,In: Klinische Pädiatrie. Stuttgart: Thieme, Jg. 235, 2023, Nr. 3, S. 192 -
Characteristics of FLT3-ITD and Efficacy of Sorafenib Treatment in Pediatric AML : A Report from AML-BFM Study GroupIn: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 142, 2023, Nr. Supplement 1: Annual Meeting Abstracts (65th ASH Annual Meeting and Exposition, 9-12 Dezember 2023, San Diego), S. 4217 – 4217DOI (Open Access)
-
Extracellular vesicles transfer chromatin-like structures that induce non-mutational dysfunction of p53 in bone marrow
34. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung ; 31.05. – 03.06.2023, Wilsede, Germany,In: Klinische Pädiatrie. Stuttgart: Thieme, Jg. 235, 2023, Nr. 3, S. 194 – 195 -
Hyperparathyroidism is associated with inferior event free survival in lymphatic childhood malignancies in a single center retrospective analysisIn: Hormone Research in Paediatrics. Basel: Karger, Jg. 96, 2023, Nr. Suppl. 4, S. 134
-
Impact-AML : A European Master Framework for Cohort Studies and Pragmatic Clinical Trials in Relapse or Refractory Acute Myeloid Leukemia
65th Annual Meeting of the American-Society-of-Hematology (ASH); DEC 09-12, 2023; San Diego, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 142, 2023, Nr. Suppl.1, S. 1533 – 1533DOI (Open Access) -
Machine Learning Provides Individualized Prediction of Outcomes after First Complete Remission in Adult AML Patients : Results from the Harmony Platform
65th Annual Meeting of the American-Society-of-Hematology (ASH); DEC 09-12, 2023; San Diego, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 142, 2023, Nr. Supplement 1, S. 62 – 62DOI (Open Access) -
Medulloblastoma EVs influence TGF-beta/SMAD1 signaling in mesenchymal stem cell
34. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung ; 31.05 – 03.06.2023, Wilsede, Germany,In: Klinische Pädiatrie. Stuttgart: Thieme, Jg. 235, 2023, Nr. 3, S. 197 -
Nucleophosmin (NPM1) Type D Genotype Is Associated with Distinct Outcome in Acute Myeloid Leukemia - an AIEOP-BFM and COG-SWOG Intergroup Collaboration
65th ASH Annual Meeting, December 9-12, 2023, San Diego, CA, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 142, 2023, Nr. Supplement 1, S. 840 – 841DOI (Open Access) -
Treatment of Molecular Relapses in Pediatric AML Saves Toxicities Prior to Hematopoietic Stem Cell Transplantation (HSCT) : Results of AMoRe2017 Trial
65th Annual Meeting of the American-Society-of-Hematology (ASH); DEC 09-12, 2023; San Diego, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 142, 2023, Nr. Supplement 1, S. 1521 – 1521DOI (Open Access) -
A randomised clinical phase 2 trial to compare treosulfan with busulfan based conditioning prior to allogeneic haematopoietic stem cell transplantation in children with non-malignant diseasesIn: Bone Marrow Transplantation. London: Springer Nature, Jg. 57, 2022, Nr. Suppl. 1, S. 91 – 92
-
Diagnostic and functional role of extracellular vesicles (EV) from blood and CSF in pediatric medulloblastoma (MB)
34. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung ; 01.-04.06.2022, Wilsede, Germany,In: Klinische Pädiatrie. Stuttgart: Thieme, Jg. 234, 2022, Nr. 3, S. 183 -
Downregulation of the Mutated WT1 Alleles in Malignant Hematopoietic Cells Via Nonsense-Mediated mRNA Decay Contradicts Their Prognostic Impact
64th Annual Meeting and Exposition of the American Society of Hematology ; December 10 - 13, 2022, New Orleans, LA, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 140, 2022, Nr. Supplement 1: 64th Annual Meeting, S. 11498 – 11499DOI (Open Access) -
Guiding Pups with Severe Hemophilia a and Their Parents from Diagnosis to a Full Prophylactic Schedule Mitigating the Risk of Bleed and the Risk for Inhibitor Formation : a Single Centre ApproachIn: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 140, 2022, Nr. Supplement 1: 64th Annual Meeting, S. 8472 – 8473DOI (Open Access)
-
ITCC-101/APAL2020D : A Randomized Phase 3 Trial of Fludarabine/Cytarabine/Gemtuzumab Ozogamycin with or without Venetoclax in Children with Relapsed Acute Myeloid Leukemia
64th ASH Annual Meeting and Exposition, 10-13 December 2022, New Orleans,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 140, 2022, Nr. Supplement 1: 64th ASH Annual Meeting Abstracts, S. 3369 – 3370DOI (Open Access) -
Identification and isolation of homogenous AML derived extracellular vesicles for MRD detection in pediatric AML
34. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung ; 01.-04.06.2022, Wilsede, Germany,In: Klinische Pädiatrie. Stuttgart: Thieme, Jg. 234, 2022, Nr. 3, S. 182 -
Molecular Relapse in Pediatric AML : Clinical Relapse May be Predicted By Increasingin MRD Level - Experiences from Real-World Data in Patients with Inv(16), t(8;21), t(9;11), t(10;11) or NPM1
64th ASH Annual Meeting and Exposition, 10-13 December 2022, New Orleans,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 140, 2022, Nr. Supplement 1: 64th ASH Annual Meeting Abstracts, S. 6326 – 6327DOI (Open Access) -
RAS Pathway Alterations in Pediatric AML PatientsIn: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 140, 2022, Nr. Supplement 1: 64th Annual Meeting, S. 6110 – 6111DOI (Open Access)
-
Rearrangements Involving 11q23/KMT2A : Mutational Landscape and Prognostic Implications ; Results of the Harmony Alliance AML Database
64th Annual Meeting and Exposition of the American Society of Hematology ; December 10 - 13, 2022, New Orleans, LA, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 140, 2022, Nr. Supplement 1, S. 551 – 554DOI, Online Volltext (Open Access) -
Revision of Complete Remission Criteria in Pediatric AML
64th ASH Annual Meeting and Exposition, 10-13 December 2022, New Orleans,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 140, 2022, Nr. Supplement 1: 64th ASH Annual Meeting Abstracts, S. 1016 – 1017DOI (Open Access) -
The extended potential of optical genome mapping (OGM) in pediatric AML compared to classical cytogenetics
34. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung ; 01.–04.06.2022, Wilsede, Germany,In: Klinische Pädiatrie. Stuttgart: Thieme, Jg. 234, 2022, Nr. 3, S. 186 -
Voxelotor bei Jugendlichen und Erwachsenen mit Sichelzellkrankheit : erste Erfahrungen aus dem deutschen Härtefallprogramm
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,In: Oncology Research and Treatment. Basel: Karger, Jg. 45, 2022, Nr. Supplement 2, S. 48DOI (Open Access) -
A Phase 1, Dose-Escalation Study of Gilteritinib Combined with Chemotherapy in Patients aged 6 Months to <21 Years with FLT3 Internal Tandem Duplication-Positive Relapsed or Refractory AML
63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 138, 2021, Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 2315 – 2317DOI (Open Access) -
An Individualized Approach to Treating Pups with Severe Hemophilia a : Which Factors Correlate with the Low Rate of Inhibitor Development?
63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 138, 2021, Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 2106 – 2107DOI (Open Access) -
Does RAD21 Co-Mutation Have a Role in DNMT3A Mutated AML? Results of Harmony Alliance AML Database
63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 138, 2021, Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 608 – 611DOI (Open Access) -
Harmony Alliance Provides a Machine Learning Researching Tool to Predict the Risk of Relapse after First Remission in AML Patients Treated without Allogeneic Haematopoietic Stem Cell Transplantation
63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 138, 2021, Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 4041 – 4044DOI (Open Access) -
Impact of Gender on Molecular AML Subclasses : a Harmony Alliance Study
63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 138, 2021, Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 3438 – 3441DOI (Open Access) -
Improved Outcome in Pediatric De Novo AML - Results of The AML-BFM 2012 Trial
53rd Congress of the international Society of Paediatric Oncology (SIOP), Virtual Congress, October 21-24, 2021,In: Pediatric Blood and Cancer. Hoboken: Wiley-Blackwell - STM, Jg. 68, 2021, Nr. S5, S. S91DOI (Open Access) -
Myeloid Leukemia Dependencies at CTCF-Enriched Long Noncoding RNA Loci
63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 138, 2021, Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 500 – 502DOI (Open Access) -
A phase I/II study of eribulin mesilate (ERI) plus irinotecan (IRI) in children with refractory or recurrent solid tumorsIn: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 38, 2020, Nr. 15_Suppl., S. 10535DOI (Open Access)
-
Sickle Cell Disease (SCD) : a single-centre experience - update
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment. Basel: Karger, Jg. 43, 2020, Nr. Suppl. 4, S. 180 – 181DOI (Open Access) -
Impact of a Risk-Adapted Treatment Approach in Pediatric AML : A Report of the AML-BFM Registry 2012
Konferenz 61st ASH Annual Meeting and Exposition, 07.-10.12.2019, Orlando, FL,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 134, 2019, Nr. Supplement_1, S. 293DOI (Open Access) -
Induction of a Leukemic Bone Marrow Niche Mediated By TGFB1 of Leukemic Blasts in Pediatric Acute Mekaryoblastic Leukemia : Results of an in Vitro and In Vivo Analysis
61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Orlando, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 134, 2019, Nr. Supplement_1, S. 3734 – 3734DOI (Open Access) -
Integrative Analysis of Pediatric Acute Leukemia Identifies Immature Subtypes That Span a T Lineage and Myeloid Continuum with Distinct Prognoses
61st ASH Annual Meeting and Exposition, 07.-10.12.2019, Orlando, FL,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 134, 2019, Nr. Supplement_1, S. 918DOI (Open Access) -
Mutational Landscape of Pediatric Acute Myeloid Leukemia : A Report of the AML-BFM Study Group with a Targeted NGS Approach in 525 Patients Integrating De Novo, Relapsed and Secondary AML
61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Oralndo, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 134, 2019, Nr. Supplement_1, S. 1398 – 1398DOI (Open Access) -
Phase II Study of Midostaurin + Chemotherapy in Pediatric Patients with Untreated, Newly Diagnosed, FLT3-Mutated Acute Myeloid Leukemia (AML)
61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Orlando, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 134, 2019, Nr. Supplement_1, S. 3835 – 3835DOI (Open Access) -
Treatment‐Related Acute Myeloid Leukemia in Children
61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Orlando, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 134, 2019, Nr. Supplement_1: 61st ASH Annual Meeting, S. 1322 – 1322DOI (Open Access) -
Hypodiploidy in Childhood Acute Myeloid Leukemia : A Retrospective Cohort Study within the International Berlin-Frankfurt-Münster Study GroupIn: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 132, 2018, Nr. Supplement 1, 60th ASH Annual Meeting Abstracts, S. 1466 – 1466DOI (Open Access)
-
Measurable Residual Disease Assessment By qPCR in Peripheral Blood Is an Informative Tool for Disease Surveillance in Childhood Acute Myeloid Leukemia
60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 132, 2018, Nr. Supplement 1, S. 2754 – 2754DOI (Open Access) -
Modelling the Progression of a Preleukemic Stage to Overt Leukemia in Children with Down Syndrome
60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 132, 2018, Nr. Supplement 1, S. 543 – 543DOI (Open Access) -
Mimicking The Bone Marrow Niche IN VITRO : Establishment Of A 3D Perfusion Culture System for Mesenchymal Stromal Cells
ACUTE LEUKEMIAS XV : Biology and Treatment Strategies, February 22– 25, 2015, Munich, Germany,,In: Annals of Hematology. Berlin: Springer, Jg. 94, 2015, Nr. Suppl. 1, S. 85 -
Whole Exome Sequencing in Single Cells from Pediatric Patients with Acute Myeloid Leukemia and NPM1/Flt3 Mutations
ACUTE LEUKEMIAS XV : Biology and Treatment Strategies, February 22– 25, 2015, Munich, Germany,In: Annals of Hematology. Berlin: Springer, Jg. 94, 2015, Nr. Suppl. 1, S. 76 -
De Novo AMLIn: Acute Myeloid Leukemia in Children / Tomizawa, Daisuke; Kolb, Edward Anders; Reinhardt, Dirk (Hrsg.). Cham: Springer Science and Business Media Deutschland GmbH, 2024, S. 105 – 122
-
Diagnosis and Classifications of Pediatric AMLIn: Acute Myeloid Leukemia in Children / Tomizawa, Daisuke; Kolb, Edward Anders; Reinhardt, Dirk (Hrsg.). Cham: Springer Science and Business Media Deutschland GmbH, 2024, S. 59 – 77
-
Clinical use of clofarabine for adults and children with leukemiaIn: Chemotherapy for Leukemia: Novel Drugs and Treatment / Ueda, Takanori (Hrsg.). Singapore: Springer Singapore, 2017, S. 287 – 309
-
Acute Myeloid Leukemia in ChildrenCham: Springer Science and Business Media Deutschland GmbH, 2024(Pediatric Oncology)
-
APAL2020SC Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias
65th ASH Annual Meeting, December 9-12, 2023, San Diego, CA, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 142, 2023, Nr. Supplement 1, S. 1492 – 1493DOI (Open Access) -
Europeanpediatric Acute Leukemia (EuPAL) Registry
65th ASH Annual Meeting, December 9-12, 2023, San Diego, CA, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 142, 2023, Nr. Supplement 1, S. 1496 – 1497DOI (Open Access) -
An Individualized Approach to Treating Pups with Severe Hemophilia A
15th Annual Congress of European Association for Haemophilia and Allied Disorders 2022, 2–4 February 2022, Virtual,In: Haemophilia: Wiley-Blackwell - STM, Jg. 28, 2022, Nr. S1: Special Issue:15th Annual Congress of European Association for Haemophilia and Allied Disorders 2022, 2–4 February 2022, Virtual Meeting, S. 37 – 37DOI (Open Access) -
Long-Term Follow-up of AML Patients Treated Intensively before the Era of Targeted Agents : a Big Data Analysis from the Harmony Collaboration
64th Annual Meeting and Exposition of the American Society of Hematology ; December 10 - 13, 2022, New Orleans,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 140, 2022, Nr. Supplement 1: 64th Annual Meeting, S. 6053 – 6055DOI (Open Access) -
Management and Outcome of Hyperleukocytosis As Early Complication in Childhood AML : an AML-BFM Experience
64th Annual Meeting and Exposition of the American Society of Hematology ; December 10 - 13, 2022, New Orleans, LA, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 140, 2022, Nr. Supplement 1: Annual Meeting Abstracts, S. 6084 – 6085DOI (Open Access) -
RUNX1 Mutations Have Distinct Prognostic and Clinical Implication in Pediatric AML : Results of the AML-BFM Study Group
64th Annual Meeting and Exposition of the American Society of Hematology ; December 10 - 13, 2022, New Orleans, LA, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 140, 2022, Nr. Supplement 1: Annual Meeting Abstracts, S. 9110 – 9112DOI, Online Volltext (Open Access) -
Second Malignancy after Childhood AML Treatment : a Retrospective Analysis of the AML-BFM Stud
64th Annual Meeting and Exposition of the American Society of Hematology ; December 10 - 13, 2022, New Orleans, LA, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 140, 2022, Nr. Supplement 1: 64th Annual Meeting, S. 6082 – 6083DOI (Open Access) -
Trial in Progress: eine multizentrische Open-label Phase IB/ II Studie zur Bestimmung der Dosierung und Sicherheit von Asciminib bei pädiatrischen Patienten mit chronischer myeloischer Leukämie in der chronischen Phase (ASC4kids)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,In: Oncology Research and Treatment. Basel: Karger, Jg. 45, 2022, Nr. Supplement 2, S. 301DOI (Open Access) -
Unexpected severe toxicity of crizotinib in combination with vinblastine : the crisp open-label phase 1B trial in pediatric patients with anaplastic large cell lymphoma (ALCL) (ITCC-053)
54th Congress of the International Society of Paediatric Oncology (SIOP), September 28 – October 1, 2022,In: Pediatric Blood and Cancer. Hoboken: Wiley-Blackwell - STM, Jg. 69, 2022, Nr. Suppl. 5, S. S321DOI (Open Access) -
Modification of total nodal Irradiation (TNI) as Part of Conditioning prior to allogeneic Stem Cell Transplantation (aSCT) for hematological Diseases using helical Tomotherapy or IMRT based on a retrospective Cohort
27. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, DEGRO 2021, virtuell,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 197, 2021, Nr. Suppl. 1: Abstracts DEGRO 2021, S. S173DOI (Open Access) -
Modular Exercise Program (MEP) in Pediatric Oncology for Intensity-Driven Exercise Control - Feasibility in Hematopoietic Stem Cell Transplantation
53rd Congress of the international Society of Paediatric Oncology (SIOP), Virtual Congress, October 21-24, 2021,In: Pediatric Blood and Cancer. Hoboken: Wiley-Blackwell - STM, Jg. 68, 2021, Nr. S5, S. S348DOI (Open Access) -
Modifikation der total nodalen Bestrahlung (TNI) als Teil der Konditionierung vor allogener Stammzelltransplantation (aSZT) bei hämatologischen Erkrankungen mittels helikaler Tomotherapie anhand einer retrospektiven Kohorte
26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 196, 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S105DOI (Open Access)